PPTA Launches New Educational Website on Donating Plasma
ANNAPOLIS, Md., Sept. 19 /PRNewswire/ — Today, more people can learn about the life-saving benefits of plasma donation through the website, http://www.donatingplasma.org/. Produced by the Plasma Protein Therapeutics Association (PPTA), this new educational website features information on plasma donation, how it helps patients with chronic, life-threatening diseases, and will help users easily find their local source plasma donation center.
PPTA designed this informative site in an effort to heighten public awareness of the importance of donating plasma. DonatingPlasma.org is the only industry-wide web site that seeks to explain and clarify the plasma donation process.
Plasma, the largest blood component, is the starting material for a wide-range of life-saving medicines used to treat life-threatening, rare, chronic, and often genetic diseases and disorders such as hemophilia, primary immunodeficiencies, alpha-1 antitrypsin deficiency and neurological and autoimmune disorders. In addition, plasma protein therapies are used to treat medical conditions such as shock, trauma and burns.
“A major goal of PPTA is to provide information to potential and current plasma donors that stresses the need for their donation, which is critical in helping to save countless lives,” said PPTA President Jan M. Bult.
The site will contain up-to-the minute information about plasma donation, including donor eligibility and health, frequently asked questions, and the time and commitment required to donate plasma,” Bult said. “We hope the site will be a resource for those interested in donating plasma and who want to learn more about the patients who are helped everyday by someone who gives plasma. With hundreds of thousands of people throughout the world depending on plasma-derived therapies, this new site should be valuable to those who are curious about ways in which they can become an essential part of saving someone’s life.”
DonatingPlasma.org offers information regarding the diseases and disorders treated with plasma protein therapies, differences in blood and plasma collection, video segments offering real-life interviews with patients, plasma donors and physicians, and links to patient group organizations and other online resources.
To view the new website, please go to http://www.donatingplasma.org/. For more information please contact Kara Flynn at (443) 458-4669 or Kym H. Kilbourne at (443) 458-4682.
ABOUT PPTA: The Plasma Protein Therapeutics Association (PPTA) is the trade association and standard setting organization for the world’s major producers of plasma-derived and recombinant analog therapies (collectively, “plasma therapies”). These therapies are used by more than 1 million people worldwide each year to treat a variety of diseases and serious medical conditions. PPTA members produce over 80 percent of the plasma therapies for the United States market and more than 60 percent worldwide. Some of the critical therapies produced by PPTA members include: blood clotting factors for people with hemophilia, intravenous immune globulin used to prevent infections in people with immune deficiencies and other serious conditions, and alpha-1 proteinase inhibitor used to treat people with alpha-1-antitrypsin deficiency, also known as genetic emphysema.
Plasma Protein Therapeutics Association
CONTACT: Kara Flynn, +1-443-458-4669, cellular, +1-443-370-1177,firstname.lastname@example.org, or Kym H. Kilbourne, +1-443-458-4682, cellular,+1-443-995-2102, email@example.com, both of the Plasma ProteinTherapeutics Association
Web site: http://www.pptaglobal.org/http://www.donatingplasma.org/